Anna L. Godfrey

6.8k total citations · 1 hit paper
36 papers, 895 citations indexed

About

Anna L. Godfrey is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Anna L. Godfrey has authored 36 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 20 papers in Hematology and 19 papers in Molecular Biology. Recurrent topics in Anna L. Godfrey's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (29 papers), Kruppel-like factors research (17 papers) and Acute Myeloid Leukemia Research (15 papers). Anna L. Godfrey is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (29 papers), Kruppel-like factors research (17 papers) and Acute Myeloid Leukemia Research (15 papers). Anna L. Godfrey collaborates with scholars based in United Kingdom, United States and France. Anna L. Godfrey's co-authors include Jyoti Nangalia, Anthony R. Green, Claire Harrison, Peter J. Campbell, Mary Frances McMullin, E. Joanna Baxter, Edwin Chen, Joe Lee, Yvonne Silber and James Hewinson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Anna L. Godfrey

34 papers receiving 882 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Life histories of myeloproliferative neoplasms inferred from phylogenies.

2022 148 citations Nicholas Williams, Joe Lee et al. Apollo (University of Cambridge) profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna L. Godfrey United Kingdom	15	664	525	455	262	78	36	895
Emmanuelle Verger France	15	468 0.7×	432 0.8×	299 0.7×	202 0.8×	39 0.5×	34	663
L. Knoops Belgium	7	426 0.6×	338 0.6×	281 0.6×	155 0.6×	31 0.4×	13	628
Alessia Moro Italy	11	259 0.4×	206 0.4×	180 0.4×	109 0.4×	28 0.4×	20	424
Luigiana Luciano Italy	14	294 0.4×	430 0.8×	116 0.3×	154 0.6×	22 0.3×	32	622
Manuel Pérez‐Encinas Spain	13	268 0.4×	325 0.6×	229 0.5×	107 0.4×	38 0.5×	46	533
Nils Mauritzson Sweden	14	244 0.4×	581 1.1×	270 0.6×	41 0.2×	78 1.0×	18	719
Daniele Cattaneo Italy	16	386 0.6×	361 0.7×	201 0.4×	196 0.7×	7 0.1×	65	624
Agnès Guerci‐Bresler France	18	1.1k 1.7×	1.4k 2.6×	125 0.3×	546 2.1×	28 0.4×	53	1.5k
Nora P. Goette Argentina	14	194 0.3×	334 0.6×	121 0.3×	80 0.3×	21 0.3×	30	485
Lurdes Zamora Spain	13	253 0.4×	328 0.6×	280 0.6×	45 0.2×	110 1.4×	55	824

Countries citing papers authored by Anna L. Godfrey

Since Specialization

Citations

This map shows the geographic impact of Anna L. Godfrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna L. Godfrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna L. Godfrey more than expected).

Fields of papers citing papers by Anna L. Godfrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna L. Godfrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna L. Godfrey. The network helps show where Anna L. Godfrey may publish in the future.

Co-authorship network of co-authors of Anna L. Godfrey

This figure shows the co-authorship network connecting the top 25 collaborators of Anna L. Godfrey. A scholar is included among the top collaborators of Anna L. Godfrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna L. Godfrey. Anna L. Godfrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Godfrey, Anna L., Andrew McGregor, Andrew J. Innes, et al.. (2025). Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline. British Journal of Haematology. 208(2). 471–485.

Guo, Jing, Klaudia Walter, Pedro M. Quirós, et al.. (2024). Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms. Nature Genetics. 56(2). 273–280. 10 indexed citations

Green, Donald P., et al.. (2024). Changing minds about climate change in Indonesia through a TV drama. Frontiers in Communication. 9. 2 indexed citations

Godfrey, Anna L., Nikolaos Sousos, Rebecca Frewin, et al.. (2024). Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice. British Journal of Haematology. 205(4). 1411–1416. 1 indexed citations

Williams, Nicholas, Joe Lee, Emily Mitchell, et al.. (2022). Life histories of myeloproliferative neoplasms inferred from phylogenies.. Apollo (University of Cambridge). 148 indexed citations breakdown →

Coorens, Tim, Grace Collord, Emily Mitchell, et al.. (2021). Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment. Blood. 137(21). 2992–2997. 17 indexed citations

Santoro, Antonella, Emily F. Calderbank, Alison Wray, et al.. (2020). Chronic lymphocytic leukemia increases the pool of peripheral blood hematopoietic stem cells and skews differentiation. Blood Advances. 4(24). 6310–6314. 1 indexed citations

Lee, Joe, Anna L. Godfrey, & Jyoti Nangalia. (2020). Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice. Blood Reviews. 42. 100708–100708. 10 indexed citations

Øbro, Nina Friesgaard, Jacob Grinfeld, Miriam Belmonte, et al.. (2020). Longitudinal Cytokine Profiling Identifies GRO‐α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia. HemaSphere. 4(3). e371–e371. 39 indexed citations

10.

McMullin, Mary Frances, Adam J. Mead, Sahra Ali, et al.. (2018). A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis. British Journal of Haematology. 184(2). 161–175. 70 indexed citations

11.

McMullin, Mary Frances, Claire Harrison, Catherine Cargo, et al.. (2018). A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. British Journal of Haematology. 184(2). 176–191. 94 indexed citations

12.

Godfrey, Anna L., Peter J. Campbell, Cathy MacLean, et al.. (2018). Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features. Journal of Clinical Oncology. 36(34). 3361–3369. 49 indexed citations

13.

Godfrey, Anna L., Peter J. Campbell, Cathy MacLean, et al.. (2017). Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial. Blood. 130. 319–319.

14.

Murphy, Ian, et al.. (2017). Imaging features of myeloproliferative neoplasms. Clinical Radiology. 72(10). 801–809. 9 indexed citations

15.

Li, Juan, David G. Kent, Anna L. Godfrey, et al.. (2014). JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease. Blood. 123(20). 3139–3151. 55 indexed citations

16.

Godfrey, Anna L., Edwin Chen, Francesca Pagano, et al.. (2012). JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone. Blood. 120(13). 2704–2707. 68 indexed citations

17.

Godfrey, Anna L. & Anthony R. Green. (2012). Genotype-Phenotype Interactions in the Myeloproliferative Neoplasms. Hematology/Oncology Clinics of North America. 26(5). 993–1015. 4 indexed citations

18.

Godfrey, Anna L., Nicholas Higgins, Philip Beer, Jenny I. O. Craig, & George S. Vassiliou. (2011). In situ thrombolysis for cerebral venous thrombosis complicating anti-leukemic therapy. Leukemia Research. 35(8). 1127–1129. 4 indexed citations

19.

Godfrey, Edmund, Anna L. Godfrey, David J. Perry, & Ashley Shaw. (2011). Don't be a clot: A radiologist's guide to haemostasis including novel antiplatelet and anticoagulant therapies. Clinical Radiology. 66(8). 693–700. 4 indexed citations

20.

Gunn‐Moore, Danièlle, et al.. (1995). The use of subcutaneous administration of radio-iodine for the treatment of feline hyperthyroidism - a study of nine cases. 23(5). 13–15. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact